Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 2, 2002 - Issue 1
Submit an article Journal homepage
18
Views
3
CrossRef citations to date
0
Altmetric
Review

Therapeutic potential of nervous system growth factors for neurodegenerative disease

David A Merrill Department of Neurosciences-0626, University of California, San Diego, La Jolla, CA 92093 USA. [email protected]
,
Armin Blesch Department of Neurosciences-0626, University of California, San Diego, La Jolla, CA 92093 USA. [email protected]
&
Mark H Tuszynski Department of Neurosciences-0626, University of California, San Diego, La Jolla, CA 92093 USA. [email protected]
Pages 89-96 | Published online: 10 Jan 2014

References

  • Bartus RT, Dean RLD, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558), 408–414 (1982).
  • •Seminal paper in the field of the cholinergic system and memory.
  • Everitt BJ, Robbins TVV. Central cholinergic systems and cognition. Ann.Rev Psychology 48(13), 649–684 (1997).
  • Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219(4589), 1184–1190 (1983).
  • •Seminal paper in the field of the cholinergic system and memory
  • Raskind MA, Peskind ER Alzheimer's disease and related disorders. Med. Clin. N Am 85(3), 803–817 (2001).
  • Korsching S, Auburger G, Heumann R, Scott J, Thoenen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EIVIBOI 4(6), 1389–1393 (1985).
  • Whittemore SR, Ebendal T, Larkfors L et al Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system. Bor. Nati Acad. Sci. USA 83(3), 817–821 (1986).
  • Dawbam D, Allen SJ, Semenenko FM. Coexistence of choline acetyltransferase and nerve growth factor receptors in the rat basal forebrain. Neurosci. Lett. 94(1–2), 138–144 (1988).
  • Holtzman DM, Li Y, Parada LF et al. p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGE Neuron 9(3), 465–478 (1992).
  • Kiss J, McGovern J, Patel AJ. Immunohistochemical localization of cells containing nerve growth factor receptors in the different regions of the adult rat forebrain. Neuroscience 27(3), 731–748 (1988).
  • Seiler M, Schwab ME. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res. 300(1), 33–39 (1984).
  • •An important early paper indicating that NGF may have a role in the adult CNS.
  • Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J. Neurosci 13(6), 2540–2550 (1993).
  • Mufson EJ, Conner JM, Kordower JH. Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis. Neuroreport 6 (7), 1063–1066 (1995).
  • ••Lack of retrograde transport of NGF inAD.
  • Scott SA, Mufson EJ, Weingartner JA, Skau Crutcher KA. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. j Neurosci 15(9), 6213–6221 (1995).
  • ••Lack of retrograde transport of NGF inAD.
  • Levi-Montakini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. I Exp. Zoology 116,321–362 (1951).
  • •Seminal work in the field of nervous system growth factors.
  • Levi-Montalcini R, Angeletti PU. Nerve growth factor. Physiol Rev 48(3), 534–569 (1968).
  • Angeletti RII, Bradshaw RA, Wade RD. Subunit structure and amino acid composition of mouse submaxillary gland nerve growth factor. Biochemistry10(3), 463–469 (1971).
  • Bocchini V, Angeletti PU. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc. Natl Acad. Sri. USA 64(2), 787–794 (1969).
  • Hefti F, Dravid A, Hartildca J. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res. 293(2), 305–311 (1984).
  • Will B, Hefti E Behavioural and neurochemical effects of chronic intraventricular injections of nerve growth factor in adult rats with fimbria lesions. Behavioural Brain Res. 17(1), 17–24 (1985).
  • Gage FH, Armstrong DM, Williams LR, Varon S. Morphological response of axotomized septal neurons to nerve growth factor. 1 Compar Neural 269 (1), 147–155 (1988).
  • Hefti E Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. j Neurosci. 6 (8), 2155–2162 (1986).
  • ••Seminal paper indicating for the first timethat NGF could prevent the loss of cholinergic neurons in the adult brain.
  • Kromer LE Nerve growth factor treatment after brain injury prevents neuronal death. Science 235(4785), 214–216 (1987).
  • Williams LR, Varon S, Peterson GM et al Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl Acad. Sri. USA 83(23), 9231–9235 (1986).
  • Fischer W, Wictorin K, Björklund A, Williams LR, Varon S, Gage FH. Amelioration of cholinergic neurone atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329(6134), 65–68 (1987).
  • •Behavioral deficits ameliorated in vivo by NGF infusions to the aged rat brain.
  • Chen KS, Gage FH. Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration.' Neurosci 15(4), 2819–2825 (1995).
  • •Gene therapy approach effectively used in rats to ameliorate behavioral deficit.
  • Fischer W, Sirevaag A, Wiegand SJ, Lindsay RM, Björldund A. Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor. Proc. Natl Acad. Sci USA 91 (18), 8607–8611 (1994).
  • Markowska AL, Koliatsos VE, Breclder SJ, Price DL, Olton DS. Human nerve growth factor improves spatial memory in aged but not in young rats. Neurosci. 14 (8), 4815–4824 (1994).
  • Martinez-Serrano A, Fischer W Björldund A. Reversal of age-dependent cognitive impairments and cholinergic neurone atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron 15(2), 473–484 (1995).
  • Koliatsos VE, Nauta HJ, Clatterbuck RE, Holtzman DM, Mobley WC, Price DL. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. Neurosci. 10(12), 3801–3813 (1990).
  • Kordower JH, Winn SR, Liu YT et al The aged monkey basal forebrain: rescue andsprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc. Natl Acad. Sci. USA 91(23), 10898–10902 (1994).
  • Tuszynski MH, U HS, Amaral DG, Gage FH. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. Neumsci. 10(11), 3604–3614 (1990).
  • •Important paper indicating the NGF can prevent cholinergic cell degeneration in the adult primate brain.
  • Ullrich A, Gray A, Berman C, Dull TJ. Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature 303(5920), 821–825 (1983).
  • •Cloning of the human NGF gene.
  • Barnett J, Baecker P, Routledge-Ward C et al Human beta nerve growth factor obtained from a baculovirus expression system has potent in vitro and in vivo neurotrophic activity. Exp. Neural 110(1), 11–24 (1990).
  • Koliatsos VE, Clatterbuck RE, Nauta HJ et al Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann. Neural 30 (6), 831–840 (1991).
  • Koliatsos VE, Applegate MD, Knasel B et al Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat. Exp. Neural 112 (2), 161–173 (1991).
  • Tuszynski MH, Sang H, Yoshida K, Gage FH. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann. Neural 30(5), 625–636 (1991).
  • Eriksdotter Jönhagen M, Nordberg A, Amberla K et al Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatric Cog. Disord 9(5), 246–257 (1998).
  • Olson L, Nordberg A, von Hoist H et al Nerve growth factor affects 11C-nicotine binding, blood flow, EEG and verbal episodic memory in an Alzheimer patient (case report). J. Neural Tiansm. Paricinsoris disease and Dementia Section. 4(1), 79–95 (1992).
  • Williams LR. Hypophagia is induced by intracerebroventricular administration of nerve growth factor. Exp. Neural 113 (1), 31–37 (1991).
  • •First description of an adverse effect of NGF using nontargeted delivery to the CNS.
  • Menesini Chen MG, Chen JS, Levi- Montalcini R. Sympathetic nerve fibers ingrowth in the central nervous system of neonatal rodent upon intracerebral NGF injections. Arch. ItaRennes de Biologie 116(1), 53–84 (1978).
  • Saffran BN,Woo JE, Mobley WC, Crutcher Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth. Brain Res. 492(1-2), 245–254 (1989).
  • Winkler J, Ramirez GA, Kuhn HG et al. Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor. Ann. Neural. 41(1), 82–93 (1997).
  • Emmett CJ, Stewart GR, Johnson RM, Aswani SP, Chan RL, Jakeman LB. Distribution of radioiodinated recombinant human nerve growth factor in primate brain following intracerebroventricular infusion. Exp. Neural. 140(2), 151–160 (1996).
  • Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 389(6648), 239–242 (1997).
  • Gage PH, Rosenberg MB, Tuszynski MH et al. Gene therapy in the CNS: intracerebral grafting of genetically modified cells. Frog: Brain Res. 86 (6648), 205–217 (1990).
  • Blau HM, Springer ML. Gene therapy-a novel form of drug delivery. N Engl. Med 333(18), 1204–1207 (1995).
  • Koeberl DD, Alexander IE, Halbert CL, Russell DW, Miller AD. Persistent expression of human clotting Factor IX from mouse liver after iv. injection of adeno-associated virus vectors. Proc. Natl Acad. Sc]. USA 94(4), 1426–1431 (1997).
  • Emerich DF, Winn SR, Harper J, Hammang JP, Baetge EE, Kordower JH. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. I Compar Neural. 349(1), 148–164 (1994).
  • Rosenberg MB, Friedmann T, Robertson RC et al Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science 242(4885), 1575–1578 (1988).
  • ••First demonstration that gene therapy inthe CNS could prevent neuronal degeneration.
  • Tuszynski MET, Roberts J, Senut MC, U HS, Gage PH. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther 3(4), 305–314 (1996).
  • ••NGF gene therapy is effective in preventing cholinergic neuron degeneration in the non-human primate brain. First use of the technique in primates that is now the subject of a human growth factor gene therapy trial.
  • Smith DE, Roberts J, Gage PH, Tuszynski MET. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc. Natl Acad. Sc]. USA 96 (19), 10893–10898 (1999).
  • ••NGF gene therapy is effective in reversingage-related cholinergic neuronal degeneration in non-human primates.
  • Conner JM, Darracq MA, Roberts J, Tuszynski MET. Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation. Proc. Natl Acad. Sc]. USA 98(4), 1941-1946 (2001).
  • Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Li. USA 89(12), 5547–5551 (1992).
  • Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 268(5218), 1766–1769 (1995).
  • •Important report describing ability to regulate gene expression from gene therapy vectors.
  • Blesch A, Uy HS, Diergardt N, Tuszynski MH. Neurite outgrowth can be modulated in vitm using a tetracycline-repressible gene therapy vector expressing human nerve growth factor. j Neurosci Res. 59(3), 402–409 (2000).
  • Blesch A, Conner JM, Tuszynski MET. Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression. Gene Ther 8, 954–960 (2001).
  • •Regulated gene therapy can switch neuronal rescue on or off in the rodent brain.
  • Paulus W, Baur I, Boyce FM, Breakefield XO, Reeves SA. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. j Viral 70(1), 62–67 (1996).

Websites

  • Progress Report on Alzheimer's disease 2000. National Institute on Aging. www.alzheimers.org

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.